Skip to main content
ASMB
NASDAQ Life Sciences

Assembly Bio's ABI-6250 Shows Clean Safety and Target Engagement in Phase 1a

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$22.785
Mkt Cap
$463.916M
52W Low
$21.795
52W High
$39.705
52W Position info
4.5% above low
Off High info
43% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

ASMB is trading near its 52-week low of $21.795 (4.5% above the low) on light trading volume (0.1× avg).

Summary

Assembly Bio unveiled positive Phase 1a data for ABI-6250, its oral NTCP inhibitor for hepatitis delta and cholestatic liver diseases. The drug was well tolerated with no serious adverse events and showed dose-dependent bile acid increases confirming target engagement. The pharmacodynamic analysis earned a Poster of Distinction at AASLD. Management plans to start Phase 2 in chronic HDV in Q4 2026 and in PBC/PSC in Q1 2027. This is the first clinical data readout for the program and de-risks the mechanism ahead of pivotal trials. The stock trades near its 52-week low, so positive data could drive a re-rating.

At the time of this announcement, ASMB was trading at $22.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $463.9M. The 52-week trading range was $21.80 to $39.71. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ASMB - Latest Insights

ASMB
Nov 12, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.95
Real-time Price: $22.87 info
Change: +$2.91 (+15%) info
Market Cap: $470.977M info
ASMB
Nov 12, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $20.19
Real-time Price: $22.87 info
Change: +$2.67 (+13%) info
Market Cap: $470.977M info
ASMB
Sep 08, 2026, 4:49 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $36.00
Real-time Price: $22.87 info
Change: -$13.14 (-36%) info
Market Cap: $470.977M info
ASMB
Aug 13, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $29.95
Real-time Price: $22.87 info
Change: -$7.08 (-24%) info
Market Cap: $470.977M info
ASMB
Jun 05, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.85
Real-time Price: $22.87 info
Change: +$0.015 (+0.07%) info
Market Cap: $470.977M info